Category: Latest News
-

NextPlat forecasts $55M 2025 revenue as restructuring drives margin expansion outlook
NextPlat Corp (NASDAQ:NXPL) said it expects to generate approximately $55 million in revenue for 2025 and anticipates continued operational improvement following strategic business refocusing efforts, with margin expansion and cost reductions projected to extend into 2026. The global consumer products and services company, which delivers healthcare and technology solutions through e-commerce and retail channels, reported…
-

Recursion Q4 earnings outperform, AI-driven drug discovery progress highlighted
Recursion Pharmaceuticals (NASDAQ:RXRX) reported fourth-quarter and full-year 2025 financial results alongside a business update, as the clinical-stage TechBio company emphasized progress in advancing its artificial intelligence–driven drug discovery platform. For the fourth quarter, Recursion posted earnings per share of $-0.21, outperforming analyst expectations of $-0.30 by $0.09. Revenue totaled $35.54 million, well above the consensus…
-

XWELL secures $31.3 million through private placement financing
XWELL, Inc. (NASDAQ:XWEL) announced it has entered into a securities purchase agreement with American Ventures, LLC for a private placement expected to generate approximately $31.3 million in gross proceeds before fees and expenses. The financing comes as the company navigates ongoing cash flow pressures, including levered free cash flow of negative $15.1 million over the…
-

CASI Pharmaceuticals to be delisted from Nasdaq effective Wednesday
CASI Pharmaceuticals Inc. (NASDAQ:CASI) announced Tuesday that its shares will be removed from trading on the Nasdaq Stock Market at the opening of business on Wednesday, February 26, 2026. The stock closed Tuesday at $0.76, near its 52-week low of $0.74, following a sharp 67% decline over the past six months. The clinical-stage biopharmaceutical company…
-

Zenvia to voluntarily delist from Nasdaq Capital Market and pursue SEC deregistration
Zenvia Inc. (NASDAQ:ZENV) announced that it has informed Nasdaq of its intention to voluntarily delist its Class A common shares from the Nasdaq Capital Market and plans to deregister with the U.S. Securities and Exchange Commission, according to a company press release issued today. The decision was approved by the company’s board of directors following…
-

Incannex approves 1-for-30 reverse stock split to regain Nasdaq compliance
Incannex Healthcare Inc. (NASDAQ:IXHL) announced Monday that its board of directors has authorized a 1-for-30 reverse stock split of the company’s common shares, according to a company press release. The reverse split will become effective at 4:01 p.m. Eastern Time on Thursday, with trading set to begin on a split-adjusted basis the following Friday under…
-

Intuitive Machines shares slide despite $175M strategic investment announcement
Intuitive Machines Inc. (NASDAQ:LUNR) shares dropped 13.3% in premarket trading on Wednesday, even after the company announced a $175 million strategic equity investment backed by global institutional investors. The space infrastructure and services firm said the new capital will be used to accelerate revenue growth initiatives and fund further development of communications and data processing…
-

ASML says artificial intelligence to become key driver of future demand
ASML (NASDAQ:ASML) said artificial intelligence is now expected to be the primary engine of future sales growth, highlighting the technology’s rapidly expanding role in shaping demand for advanced semiconductor manufacturing equipment. The Dutch company, the world’s leading supplier of lithography systems used to produce cutting-edge chips, previously believed AI would represent only a “limited portion”…
-

Astec Industries shares jump after earnings beat and record quarterly revenue
Astec Industries Inc. (NASDAQ:ASTE) reported fourth-quarter results on Wednesday that exceeded analyst expectations, supported by strong revenue growth, sending shares nearly 6% higher in pre-market trading. The company posted adjusted earnings per share of $1.06, comfortably above the consensus forecast of $0.80 by $0.26. Quarterly revenue reached a record $400.6 million, surpassing analyst estimates of…
-

Acadia Healthcare shares tick higher after Q4 revenue beat despite earnings miss
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reported mixed fourth-quarter results on Wednesday, with revenue surpassing expectations while adjusted earnings missed analyst forecasts and full-year guidance came in below consensus estimates. Shares rose 1.40% in pre-market trading following the announcement. The behavioral healthcare provider generated fourth-quarter revenue of $821.5 million, representing a 6.1% year-over-year increase and exceeding…